Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design.
Amcheslavsky A, Wallace AL, Ejemel M, Li Q, McMahon CT, Stoppato M, Giuntini S, Schiller ZA, Pondish JR, Toomey JR, Schneider RM, Meisinger J, Heukers R, Kruse AC, Barry EM, Pierce BG, Klempner MS, Cavacini LA, Wang Y.
Amcheslavsky A, et al. Among authors: giuntini s.
Sci Rep. 2021 Feb 2;11(1):2751. doi: 10.1038/s41598-021-81895-0.
Sci Rep. 2021.
PMID: 33531570
Free PMC article.